2026 SPS Denver | Caplacizumab in the Immune-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Setting. A Real-World Evidence Review of the CAPLA 1000+ Project
0% Complete
Course Overview
NA
Course Content
Course Details
- Duration
- 0.00 hour
- Released
- May 23, 2026
- Last Review
- May 23, 2026
- Expires
- May 23, 2029
Objectives
NA
Target Audience
Pharmacists
Faculty & Disclosure
Faculty
Jorge J. Garcia, PharmD, MS, MHA, MBA, FACCC, FACHE
Disclosure
NA
Accreditation
NA
